FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.41B
AUM Growth
-$85.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$78.7M
2
+$14.8M
3
+$13.5M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$10.2M
5
PVLA
Palvella Therapeutics
PVLA
+$7.66M

Top Sells

1
+$41.7M
2
+$31.3M
3
+$30.6M
4
PCVX icon
Vaxcyte
PCVX
+$27.8M
5
TYRA icon
Tyra Biosciences
TYRA
+$17.2M

Sector Composition

1 Healthcare 99.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$409M 16.98%
15,916,418
+3,061,224
2
$272M 11.28%
6,570,392
3
$157M 6.52%
3,383,950
4
$124M 5.13%
788,460
-200,000
5
$122M 5.08%
8,785,284
6
$111M 4.62%
1,754,834
7
$110M 4.58%
5,985,347
8
$105M 4.34%
1,869,808
-547,144
9
$104M 4.33%
3,800,457
+40,000
10
$87.9M 3.65%
1,587,527
11
$82.1M 3.41%
10,109,279
12
$48.7M 2.02%
19,391,687
13
$44.2M 1.83%
539,405
-340,000
14
$43.9M 1.82%
10,664,774
+3,283,684
15
$43.6M 1.81%
997,455
16
$41.4M 1.72%
4,887,867
+1,200,000
17
$35.2M 1.46%
1,069,754
+25,600
18
$33.9M 1.41%
1,271,245
-1,561,622
19
$31.4M 1.3%
699,159
-176,508
20
$31.4M 1.3%
3,888,238
-254,617
21
$27.7M 1.15%
658,715
+25,000
22
$26.6M 1.1%
8,660,379
+502,994
23
$22.1M 0.92%
770,000
24
$22M 0.91%
10,617,062
25
$20.8M 0.86%
1,573,719
-635,470
1
2 3